Melrose Park, USA

Fresenius Kabi USA develops, manufactures and markets injectable pharmaceuticals, with important products in the oncology, anti-infective, anaesthetic / analgesic and critical care fields. Fresenius Kabi USA operates out of three sites, located in upstate New York, North Carolina and Illinois.

Our production facility in Melrose Park, Illinois, is located in the outskirts of Chicago and just 5 miles from O`Hare International Airport. The plant employs approximately 800 people. A $250M expansion project is underway utilizing leading industry isolator filling technology, additional lyophilizers and warehouse space.

 

Technologies:

  • Lyophilization
  • Aseptic liquid filling
  • Terminal sterilization

Containers:

Certificates:

  • US-FDA
  • Canada-Health Canada

Market:

  • US
  • Canada
  • China
  • Russia